SCHEMBL7608447

SCHEMBL7608447

Cn1c(=O)n(COc2ccc(Cl)cc2)c(=O)c2c1ncn2Cc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.67
HIF1A Q16665 1/20 0.67
SMN1; SMN2 Q16637 5/20 0.64
RXFP1 Q9HBX9 2/20 0.64
ADORA2B P29275 1/20 0.64
LMNA P02545 3/20 0.63
MAPK1 P28482 1/20 0.63
HTT P42858 2/20 0.57
UBE2N P61088 2/20 0.57
GLA P06280 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PDE1A P54750 1/20 0.56
PDE1B Q01064 1/20 0.56
PDE1C Q14123 1/20 0.56
TP53 P04637 1/20 0.53
ALDH1A1 P00352 2/20 0.51
CASP1 P29466 1/20 0.49
TSHR P16473 1/20 0.49
ABCC8 Q09428 1/20 0.49
KCNJ11 Q14654 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7603292 0.85 POLB (0.74) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL11014928 0.84 POLB (0.83) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL7465110 0.84 POLB (0.71) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL7608305 0.84 POLB (0.75) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL7603804 0.81 POLB (0.67) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL7604677 0.81 POLB (0.67) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL5718879 0.79 POLB (0.65) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL1944405 0.79 ADORA2B (1.00) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL3116289 0.79 POLB (0.86) POLBHIF1ASMN1; SMN2RXFP1ADORA2B
SCHEMBL7564474 0.78 POLB (0.73) POLBHIF1ASMN1; SMN2RXFP1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
CN-1066146-C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof AVENTIS PHARMACEUTICALS AG (DE) 2001-05-23 CN disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
CN-1169993-A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof HOECHST AG (DE) 1998-01-14 CN disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed